FDA Approval Based on Novel Surrogate Endpoints: Lessons From the Voluntary Withdrawal of Voxelotor in Sickle Cell Disease
Skip to main content
eScholarship
Open Access Publications from the University of California
Refine Search

UCSF

UC San Francisco Previously Published Works bannerUCSF

FDA Approval Based on Novel Surrogate Endpoints: Lessons From the Voluntary Withdrawal of Voxelotor in Sickle Cell Disease

Published Web Location

https://doi.org/10.1002/ajh.27635

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.


Top